NIKKI BEHNER: Open Payments
NPI 1548472244 · MOUNT VERNON, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,534 in 67 payments from 10 companies in 2025. Trend: 2023 $2,150 · 2024 $2,480 · 2025 $1,534
Food & beverage: $1,534
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $444 |
| E.R. Squibb & Sons, L.L.C. | 17 | $260 |
| Otsuka America Pharmaceutical, Inc. | 9 | $206 |
| ABBVIE INC. | 12 | $177 |
| Axsome Therapeutics, Inc. | 3 | $154 |
| Neurocrine BioSciences, Inc. | 3 | $119 |
| Alkermes, Inc. | 3 | $64 |
| Teva Pharmaceuticals USA, Inc. | 2 | $54 |
| Janssen Pharmaceuticals, Inc | 2 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
Products named: CAPLYTA, COBENFY, VRAYLAR, Auvelity, ABILIFY MAINTENA, INGREZZA, ABILIFY ASIMTUFII, ARISTADA.
Industry payments across WA — which companies pay providers there.
